Lisata Therapeutics Inc (LTS:0HS8)
$ 3.255 0 (0%) Market Cap: 28.95 Mil Enterprise Value: -14.23 Mil PE Ratio: 0 PB Ratio: 0.67 GF Score: 37/100

Lisata Therapeutics Inc at OTC Markets Life Science Investor Forum (Virtual) Transcript

Mar 09, 2023 / 03:30PM GMT
Release Date Price: $3.11
Matt Liteplo
OTC Markets Group - Advisor Relations Associate

Hello, and welcome to Virtual Investor Conferences. My name is Matt Liteplo, and on behalf of OTC Markets, we're very pleased you have joined us for our next live presentation from Lisata Therapeutics, Inc.

(Operator Instructions) All of today's presentations will be recorded and available for 24/7 replay. At this point, I'm very pleased to welcome Dr. David Mazzo, Chief Executive Officer of Lisata Therapeutics, Inc., which trades on NASDAQ under the symbol LSTA. Welcome, David.

David Mazzo
Lisata Therapeutics, Inc. - CEO

Thank you, Matt, and good morning, everyone. And thank you very much for taking the time to listen to my presentation and give me the opportunity to introduce you to the Lisata Therapeutics. As with all public companies, I'll just mention that I will be making forward-looking statements throughout the presentation and ask that you keep these in mind as you take investment decisions.

So let's start with a very simple summary. What is Lisata? Well, Lisata is a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot